Glimepiride Tablet
Product Images NDC 51655-565

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Glimepiride (NDC 51655-565). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Northwind Health Company, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label (51655 565 26 Master Bottle Label Approval Rev A 01 21)

Label for Glimepiride Tablets USP 2 mg, oral tablets in a bottle containing 90 tablets. The label includes storage instructions, dosage note to see package insert, and the labeler Northwind Health Company, LLC. It shows NDC 51655-565 and mentions prescription use only.*

FDA Label Image

Structure (Structure)

Chemical structure of glimepiride, the active ingredient shown in the image. The structure depicts the molecular arrangement including functional groups and ring systems characteristic of glimepiride.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.